Omitting Radiation Therapy From Breast Cancer Treatment May Be Possible for Younger Post-Menopausal Women With Early-Stage HR-Positive/HER2-Negative Breast Cancer

2 years ago 70

A clinical trial suggests younger post-menopausal women with early-stage HR-positive/HER2-negative breast cancer may safely omit radiation therapy if they continue endocrine therapy.

1. Homepage
2. Breast Cancer
3. Omitting Radiation Therapy From Breast Cancer Treatment May Be Possible for Younger Post-Menopausal Women With Early-Stage HR-Positive/HER2-Negative Breast Cancer